These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 1668142)
1. Incidence of hepatitis C virus infection in burn patients: detection of anti-C100, anti-C33c and anti-Core antibodies. Coursaget P; Lesage G; Simpson B; Mayelo V; Le Cann P Biomed Pharmacother; 1991; 45(10):445-9. PubMed ID: 1668142 [TBL] [Abstract][Full Text] [Related]
2. Enhanced sensitivity of a second generation ELISA for antibody to hepatitis C virus. Bresters D; Cuypers HT; Reesink HW; Schaasberg WP; van der Poel CL; Mauser-Bunschoten EP; Houghton M; Choo QL; Kuo G; Lesniewski R Vox Sang; 1992; 62(4):213-7. PubMed ID: 1379394 [TBL] [Abstract][Full Text] [Related]
3. Antibodies against non-structural c100/3 and structural core antigen of hepatitis C virus (HCV) in hemodialysis patients. Yoshida CF; Takahashi Y; Vanderborght BO; Rouzere CD; França MS; Takahashi C; Takamizawa A; Yoshida I; Schatzmayr HG Rev Inst Med Trop Sao Paulo; 1993; 35(4):315-21. PubMed ID: 7509506 [TBL] [Abstract][Full Text] [Related]
4. HCV infection and its clinical features in recipients of blood screened for HCV (C100-3) antibody. Ito S; Honda H; Hibino S; Nii C; Kamamura M; Nishikado T; Fujikawa H; Saijo T; Okamura S; Shimizu I J Gastroenterol Hepatol; 1994; 9(1):19-25. PubMed ID: 8155861 [TBL] [Abstract][Full Text] [Related]
5. Anti-c100 antibodies to hepatitis C virus in patients with chronic hepatitis C virus infection treated with interferon. Nakano Y; Kiyosawa K; Sodeyama T; Tanaka E; Yoshizawa K; Furuta K; Nakatsuji Y; Urushihara A; Furuta S Scand J Gastroenterol; 1993 Apr; 28(4):335-42. PubMed ID: 8387696 [TBL] [Abstract][Full Text] [Related]
6. Anti-hepatitis C virus screening will reduce the incidence of post-transfusion hepatitis C also in low-risk areas. Mathiesen UL; Ekermo B; Foberg U; Franzén L; Frydén A; Norlin R; Pettersson LG; Sterling H; Widell A; Bodemar G Scand J Gastroenterol; 1992 Jun; 27(6):443-8. PubMed ID: 1321487 [TBL] [Abstract][Full Text] [Related]
7. Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology. Contreras M; Barbara JA; Anderson CC; Ranasinghe E; Moore C; Brennan MT; Howell DR; Aloysius S; Yardumian A Lancet; 1991 Mar; 337(8744):753-7. PubMed ID: 1672391 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus detection is facilitated by the combined use of c100 protein and GOR epitope. Hayashi J; Nakashima K; Hirata M; Noguchi A; Akazawa K; Maeda Y; Kashiwagi S Gastroenterol Jpn; 1992 Oct; 27(5):632-7. PubMed ID: 1385249 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis virus infection (HBV and HCV) in eleven Japanese hemodialysis units. Oguchi H; Miyasaka M; Tokunaga S; Hora K; Ichikawa S; Ochi T; Yamada K; Nagasawa M; Kanno Y; Aizawa T Clin Nephrol; 1992 Jul; 38(1):36-43. PubMed ID: 1499167 [TBL] [Abstract][Full Text] [Related]
10. Also with a restrictive transfusion policy, screening with second-generation anti-hepatitis C virus enzyme-linked immunosorbent assay would have reduced post-transfusion hepatitis C after open-heart surgery. Mathiesen UL; Karlsson E; Foberg U; Frydén A; Franzén L; Widell A; Bodemar G Scand J Gastroenterol; 1993 Jul; 28(7):581-4. PubMed ID: 7689744 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis C as the cause of chronic non-A, non-B hepatitis: high sensitivity of simultaneous measurement of core and non-structural antibodies. Lin R; Yatuhashi H; Yano M; Farrell GC J Gastroenterol Hepatol; 1992; 7(5):459-62. PubMed ID: 1382656 [TBL] [Abstract][Full Text] [Related]
12. Changes in antibodies to specific hepatitis C virus antigens with interferon-alpha therapy: analysis by recombinant immunoblot assay. Yuki N; Hayashi N; Hagiwara H; Takehara T; Katayama K; Kasahara A; Fusamoto H; Kamada T Am J Gastroenterol; 1993 Jun; 88(6):914-8. PubMed ID: 7684885 [TBL] [Abstract][Full Text] [Related]
13. [Incidence of hepatitis C virus in kidney transplantation recipients]. Catelle A; Edert D; Renoult E; Cao Huu T Agressologie; 1992; 33 Spec No 2():99-102. PubMed ID: 1340101 [TBL] [Abstract][Full Text] [Related]
14. Outcome of HCV infection after renal transplantation. Goffin E; Pirson Y; Cornu C; Geubel A; Squifflet JP; van Ypersele de Strihou C Kidney Int; 1994 Feb; 45(2):551-5. PubMed ID: 8164444 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of hepatitis C virus infection among long-term hemodialysis patients: detection of hepatitis C virus RNA in plasma. Sakamoto N; Enomoto N; Marumo F; Sato C J Med Virol; 1993 Jan; 39(1):11-5. PubMed ID: 7678636 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis--a multicenter study. Gladziwa U; Schlipköter U; Lorbeer B; Cholmakow K; Roggendorf M; Sieberth HG Clin Nephrol; 1993 Jul; 40(1):46-52. PubMed ID: 7689431 [TBL] [Abstract][Full Text] [Related]
17. Effect of screening for hepatitis C virus antibody and hepatitis B virus core antibody on incidence of post-transfusion hepatitis. Japanese Red Cross Non-A, Non-B Hepatitis Research Group. Lancet; 1991 Oct; 338(8774):1040-1. PubMed ID: 1681356 [TBL] [Abstract][Full Text] [Related]
18. Improved serodiagnosis of posttransfusion hepatitis C virus infection by a second-generation immunoassay based on multiple recombinant antigens. Wang JT; Wang TH; Lin JT; Sheu JC; Lee CZ; Chen DS Vox Sang; 1992; 62(1):21-4. PubMed ID: 1374579 [TBL] [Abstract][Full Text] [Related]
19. Antibodies to hepatitis C virus and hepatitis C virus infection. Yuki N; Hayashi N; Kasahara A; Hagiwara H; Fusamoto H; Kamada T Gastroenterol Jpn; 1993 May; 28 Suppl 5():76-9. PubMed ID: 7689512 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis type C virus infection in patients with type B chronic liver disease. Doi T; Yamada G; Endo H; Nishimoto H; Takahashi M; Miyamoto R; Fujiki S; Shimomura H; Mizuno M; Tsuji T Gastroenterol Jpn; 1992 Oct; 27(5):617-23. PubMed ID: 1330796 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]